Searched for
SUPRIYA LIFESCIENCE REVENUE
Supriya Lifescience shares surge 17% on strong Q4 earnings; PAT rises 47% YoYSupriya Lifescience shares jumped over 16% after the company posted a strong Q4FY26 performance, with PAT rising 47% YoY and revenue surgin...- Supriya Lifescience targets Rs 1,600-cr revenue in three years on capacity expansionSupriya Lifescience plans to reach Rs 1,600 crore revenue in three years. New facilities in Lote MIDC and Ambernath will drive this growth....
- Prasol Chemicals files papers with Sebi to mobilise Rs 500-cr via IPOSpecialty chemicals manufacturer Prasol Chemicals has filed preliminary papers with capital markets regulator Sebi to raise Rs 500 crore th...
- Virupaksha Organics files draft papers with Sebi for Rs 740 crore IPOPharmaceutical company Virupaksha Organics has filed preliminary papers with capital markets regulator Sebi to raise Rs 740 crore through a...
- Anlon Healthcare IPO GMP: Will healthy subscription lead to a strong listing tomorrow?Anlon Healthcare, a Gujarat-based API and pharma intermediates manufacturer, will debut on the stock exchanges on Wednesday after its Rs 12...
- Supriya Lifescience expects to double revenue to Rs 1,000 crore in next 3 yearsSupriya Lifescience aims to double revenue to Rs 1,000 crore by venturing into higher-margin niche segments. Led by Satish Wagh, it is expa...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%With Nifty touching a new high, there is a high probability that a large number of investors will be looking at the returns of their portfo...
- Supriya Lifesciences Q3 Results: Net profit triples to Rs 30 croreRevenues rose 33% YoY to Rs 140 crore in Q3FY24. Earnings before interest, taxes, depreciation and amortisation (EBITDA) for Q3FY24 almost ...
- Supriya Lifescience to bet on R&D, expansion to grow revenuesSupriya Lifescience, an active pharmaceutical ingredient (API) maker based in Mumbai, aims to double its revenue in the next three years. T...
- For investors with slightly higher risk appetite: 4 smallcap stocks with upside potential of up to 41%After a phase of correction the small cap stocks segment has been able once again inch upward. Lower oil prices, softer inflation numbers a...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 25%As broader market indices witness minor consolidation, which normally happens when they are close to all time high as some resistance is bo...
- Top picks of the week: 4 stocks with consistent score improvement and upside potential of more than 52%In the two months of the volatile phase with a bearish bias, market breadth has been the biggest casualty. Even in such times during this p...
- Market movers: Supriya Lifescience gets reality check; Hikal back in demand after 11 sessionsSupriya Lifescience plunged over 17 per cent after the company said its profits declined 32 per cent sequential
- Bullish on 3 stocks that listed last year: Hemang Jani“From among the 60 odd IPOs that were launched, betting on Supriya Life, GR Infra and Devyani International.”
- Supriya Lifescience to sustain 40% plus EBITDA margin going forward: Saloni Wagh“Our business model is completely derisked and the company has very strong fundamentals. Whatever percentage of growth we have seen in the ...
- Supriya Lifescience IPO opens: Here's what brokerages are suggestingA day before the IPO, Supriya Lifesciences raised Rs 315 crore from 18 anchor investors, allocating them 1,14,96,351 equity shares for Rs 2...
- Supriya Lifescience a good bet on healthy growth, valuationsActive pharmaceutical ingredient (API) manufacturer Supriya Lifescience has a niche basket of 38 APIs across therapeutic segments and it ea...
- Supriya Lifescience IPO opens this week. Check dates, price band, other detailsInvestors can bid for a minimum of 54 equity shares and in multiple of 54 thereof. The IPO can be subscribed till December 20, Monday. The ...
- Supriya Lifescience files DRHP to raise Rs 1,200 crore via IPOThe IPO consists of a fresh issue of shares worth Rs 200 crore and an offer of sale (OFS) of shares worth up to Rs 1,000 crore held by its ...
- Record export growth: The bustling new foreign markets for Indian productsIndian companies in recent years have looked beyond the US-EU-China axis for investments.
Load More
